Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

ulcerative colitis

Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis
Nicholas E Burr, David J Gracie, Christopher J Black, Alexander C Ford

Gut Oct 2022, 71 (10) 1976-1987; DOI: 10.1136/gutjnl-2021-326390
Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry
Florence-Damilola Odufalu, Millie Long, Kirk Lin, Uma Mahadevan

Gut Sep 2022, 71 (9) 1766-1772; DOI: 10.1136/gutjnl-2021-325317
Bidirectional brain–gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis
Keeley M Fairbrass, Jessica Lovatt, Brigida Barberio, Yuhong Yuan, David J Gracie, Alexander C Ford

Gut Sep 2022, 71 (9) 1773-1780; DOI: 10.1136/gutjnl-2021-325985
Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn’s disease
Julien Kirchgesner, Rishi J Desai, Maria C Schneeweiss, Laurent Beaugerie, Sebastian Schneeweiss, Seoyoung C Kim

Gut Sep 2022, 71 (9) 1781-1789; DOI: 10.1136/gutjnl-2022-327002
Response to: Correspondence on "PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system" by Wong et al
Marietta Iacucci, Tommaso Lorenzo Parigi, Alina Bazarova, Subrata Ghosh, Vincenzo Villanacci, Xianyong Gui

Gut Jul 2022, gutjnl-2022-327980; DOI: 10.1136/gutjnl-2022-327980
Deciphering the vedolizumab dosing conundrum in IBD: when less is more
Timon Erik Adolph, Britta Siegmund

Gut Aug 2022, 71 (8) 1455-1456; DOI: 10.1136/gutjnl-2021-325893
Letter to the editor: Genetically determined IBD is associated with decreased risk of Alzheimer’s disease: a Mendelian randomisation study
Xingzhi Guo, Li Chong, Xin Zhang, Rui Li

Gut Aug 2022, 71 (8) 1688-1689; DOI: 10.1136/gutjnl-2021-325869
Maternal antibiotic exposure during pregnancy and risk of IBD in offspring: a population-based cohort study
Manasi Agrawal, Gry Poulsen, Jean-Frederic Colombel, Kristine Højgaard Allin, Tine Jess

Gut Jun 2022, gutjnl-2022-327724; DOI: 10.1136/gutjnl-2022-327724
Correspondence on “PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system” by Gui et al
Emily C L Wong, Parambir S Dulai, Neeraj Narula

Gut Jun 2022, gutjnl-2022-327661; DOI: 10.1136/gutjnl-2022-327661
Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
Simeng Lin, Louis HS Lau, Neil Chanchlani, Nicholas A Kennedy, Siew C Ng

Gut Jul 2022, 71 (7) 1426-1439; DOI: 10.1136/gutjnl-2021-326784

Pages